CN1593424A - Novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application - Google Patents
Novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application Download PDFInfo
- Publication number
- CN1593424A CN1593424A CN 200410013492 CN200410013492A CN1593424A CN 1593424 A CN1593424 A CN 1593424A CN 200410013492 CN200410013492 CN 200410013492 CN 200410013492 A CN200410013492 A CN 200410013492A CN 1593424 A CN1593424 A CN 1593424A
- Authority
- CN
- China
- Prior art keywords
- phthalocyanine
- amphipathic
- sulfonic acid
- salt
- phthalonitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Disclosed is a novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application, wherein 4-sulfonic acid potassium phthalonitrile and 4-phthaloyl formimidoyl phthalonitrile are used as raw material, sulfonic acid potassium substituted phthalocyanine and phthaloyl formimidoyl substituted phthalocyanine are produced in reaction of the alcoholic lithium solution as precursor, then cyclization reaction is conducted in ethylene glycol ethyl ether, thus producing 2 (sulfonic potassium) 2 (phthaloyl formimidoyl) phthalocyanine lithium intermediate, the intermediate reacts with metal salt in DMF, producing amphipathic phthalocyanine complex of the related central metal, the product yield is separated, purified, and mixed with polyoxyethylene 35 ricinus oil, 1,2-methyl ethylene glycol and physiological saline solution.
Description
Technical field:
The present invention relates to the new preparation method and the application thereof of a class amphipathic phthalocyanine anticancer photosensitizer, such coordination compound is used to be mixed with pharmaceutical photosensitizer, is applied to the optical dynamic therapy cancer and as photosensitive disinfectant.
Background technology:
Phthalocyanine and its derivant not only are widely used as dyestuff, and have obtained application as photoelectric material, nonlinear optical material, catalyst, optical recording medium material etc. in high-tech sector.Particularly this compounds can substitute onto periphery or axial location by the group with biologically active, make its not only in the 600-800nm red light district a certain specific wavelength strong absorption is arranged, and biologically active and, thereby be the of new generation comparatively ideal photosensitizer of optical dynamic therapy cancer to the targeting of tumor.
We have designed and have synthesized a kind of amphipathic phthalocyanine Zn complex ZnPcS
2P
2K
2(wherein S is a hydrophilic sulfonic acid potassio, and P is the lipotropy phthalimidomethyl, and Pc is the phthalocyanine ring).This coordination compound cell and animal experiment before clinical studies show that have low toxicity, characteristics such as safety, high cancer suppressing ratio.This coordination compound and manufacture method thereof, and the application in the system cancer therapy drug have obtained Chinese invention patent, and its patent No. is ZL96117137.5
[1]
In this patent, amphipathic phthalocyanine Zn complex ZnPcS
2P
2K
2Be to adopt the at first synthetic Phthalocyanine Zinc ZnPc that replaces that do not have, then Phthalocyanine Zinc added oleum, polyformaldehyde and phthalic amide and obtain in concentrated sulphuric acid by " treating different things alike " method
[1]This synthetic method by-product is many, separating difficulty is big, target product ZnPcS
2P
2K
2Yield low.The objective of the invention is to provide the novel synthesis of this coordination compound, make it easy to industrialization and be applied to make the photosensitizer that optical dynamic therapy is used.
Up to now, Shang Weijian has the successful report that uses hydrophilic sulfonic acid potassio replacement phthalonitrile and the direct cyclization of lipotropy phthalimide replacement phthalonitrile to prepare the amphipathic phthalocyanine metal complex.People such as S.V.Kudredich
[2]Once reported to have synthesized and had a hydrophilic sulfonic group; the phthalocyanine Zn complex of three lipotropy tert-butyl groups; yet they synthesize the Phthalocyanine Zinc that contains the nitro and the tert-butyl group with the nitrophthalonitrile of similar performance and tert-butyl o benzene dicarbonitrile by the probability condensation method; then with the nitro on the phthalocyanine through the reduction; sulfonylation; series of steps such as hydrolysis are transformed into sulfonic group; rather than obtain by sulfonic group phthalonitrile and the direct cyclization of tert-butyl o benzene dicarbonitrile, and they do not synthesize in this way yet and have two sulfonic groups; the phthalocyanine Zn complex of two tert-butyl groups.
People such as C.C.Leznoff
[3]Once from 3,3-dimethyl-1-butyl-4,5-dinitrile benzene or phthalonitrile prepare half phthalocyanine, have synthesized the ortho position substituted phthalocyanine with phthalonitrile or methoxyl group phthalonitrile respectively by these half phthalocyanine intermediate then, 2,3,9,10-four (3,3-dimethyl-1-butyl) phthalocyanine Zn complex and 2,3,9,10-tetramethoxy phthalocyanine Zn complex.People such as Nagno Kobayashi
[4]Also use 3,6-diphenyl phthalonitrile and 2,3-dintrile-5,6-diethyl-1, the 4-pyrazine has synthesized the phthalocyanine nickel complex that the ortho position replaces by the method that at first generates half phthalocyanine intermediate.But the substituent group in these half phthalocyanines is all lipophilic group, and, do not see their report with this method synthesizing amphipathic phthalocyanine yet.
Summary of the invention:
The present invention has overcome that existing synthetic method by-product is many, separating difficulty is big, target product ZnPcS
2P
2K
2The low defective of yield, the new preparation method and the application thereof of the amphipathic phthalocyanine anticancer photosensitizer that a kind of technology is simple, the product yield is high are provided.
The new method of synthetic anticancer photosensitizer is promptly to amphipathic phthalocyanine Zn complex (ZnPcS in our the authorized ZL96117137.5 patent of invention
2P
2K
2) renewal of manufacture method.Be characterized in that with hydrophilic 4-sulfonic acid potassio phthalonitrile and lipophilic 4-phthalimidomethyl phthalonitrile be raw material, at first allow these two kinds of starting materials in lithium alkoxide solution, react respectively, to generate corresponding sulfonic acid potassio " half phthalocyanine " and phthalimidomethyl " half phthalocyanine ", presoma as ring-closure reaction, then, these two kinds of presomas are pressed corresponding mol ratio, in ethylene glycol, carry out ring-closure reaction, after reaction finishes, steam ethylene glycol, solid residue is dissolved in N, in the dinethylformamide (DMF), and add corresponding metal salt (as zinc salt, iron salt, mantoquita, cobalt salt, nickel salt, aluminum salt), 120-200 ℃ of reaction, making main component is the phthalocyanine metal complex of two (sulfonic acid potassio) two (phthalimidomethyls).By-product is the phthalocyanine metal complex that contains sulfonic acid potassio and phthalimidomethyl that number does not wait.By the column chromatography separation method, obtain target product at last---two (sulfonic acid potassio) two (phthalimidomethyl) phthalocyanine metal complexes.
The present invention and the existing oleum of using, polyformaldehyde, phthalimide is compared with the manufacture method of " treating different things alike " synthesizing amphipathic phthalocyanine metal complex that no substituted phthalocyanine metal complex reacts in concentrated sulphuric acid, it is simple to have the product composition, target product productive rate height, be easy to separation and purification and industrialization, advantage such as production cost is low.
Characteristics of the present invention be at first with the lithium alkoxide method make respectively that a kind of hydrophilic sulfonic acid potassio replaces and " half phthalocyanine " of a kind of lipotropy phthalimidomethyl replacement as presoma, then in amphipathic solvent, obtain two substituted phthalocyanine lithium-complexes as intermediate by ring-closure reaction, in DMF, intermediate is changed into target product at last with respective metal salt.
Description of drawings:
Fig. 1 is a main chemical reactions formula of the present invention.
The specific embodiment:
Embodiment one
(1) takes back in the there-necked flask of stream condensing tube, airway in 500ml; under nitrogen protection; add new absolute methanol 100ml and the lithium metal 62mg that steams; magnetic agitation to lithium metal dissolves fully; the 4-sulfonic acid potassio phthalonitrile that adds 4.30g then; be warming up to 50 ℃, keep reaction 25 minutes, be cooled to room temperature.
(2) have in the 1000ml there-necked flask of the same device toward another, feed argon, and new anhydrous ethylene glycol 400ml and the lithium metal 62mg that steams of adding, magnetic agitation to lithium metal dissolves fully, add 5.0g4-phthalimidomethyl phthalonitrile then, be warming up to 80 ℃, keep reaction 60 minutes
(3) (3) slowly add (1) solution in (2) solution under nitrogen protection, and keep 80 ℃, and the limit border ring steams methanol.Reaction temperature is increased to 150 ℃ at last, reacted 4 hours.
(4) after reaction finished, distilling under reduced pressure went out ethylene glycol, adds 200 milliliters of DMF and 12g zinc acetate successively then in residual solids, and 120 ℃ of reactions 4 hours, decompression steamed DMF more at last, obtained solid, shaped reaction back mixture.
(5) in the mixture of reaction back, add 500 milliliters of frozen water solution that KCl is saturated, after fully stirring, filter and discard filtrate, keep filter cake.
(6) filter cake is leached after-filtration with 1000ml 80% alcoholic acid aqueous solution, filtrate is through C
18Chromatographic column is carried out post separation, purification by concentration of alcohol from the 5%-95% linear gradient with ethanol-water solution.Collect two (sulfonic acid potassio) two (phthalimidomethyl) Phthalocyanine Zinc components.
(7) alcoholic solution that contains two (sulfonic acid potassio) two (phthalimidomethyl) Phthalocyanine Zinc components that (6) is obtained after reduction vaporization removes ethanol by rotation, carries out lyophilization, obtains the aeruginous solid product, is target product.Productive rate 12%.The Q band maximum absorption spectrum of product in DMF is 677nm,
(8) preparation optical dynamic therapy photosensitizer, follow these steps to carry out, in the pharmaceutical purpose class 100 clean room, take by weighing a certain amount of two (sulfonic acid potassio) two (phthalimidomethyl) Phthalocyanine Zinc, be dissolved in by Cremophor EL, 1, in 2-propylene glycol, the solution of 10% sodium chloride injection by 1: 10: 4.5 (volume ratio) composition, add sterilized water for injection at last, be diluted to normal concentration, and make injection by fill.
Embodiment two
With (1) among the embodiment one and (2) process, then (2) solution is slowly added in (1) solution, other processes are with embodiment one, and the productive rate of ideal product is 12.8%.
Embodiment three
The reaction temperature of process among the embodiment one (1) changes 60 ℃ into, and the response time changes 10 minutes into, and the reaction temperature of process (2) changes 100 ℃ into, and the response time changes 40 minutes into, and other processes are constant, and the productive rate of ideal product is 11%.
Embodiment four
Change process (1) and middle sulfonic acid potassio phthalonitrile of process (2) and phthalimidomethyl phthalonitrile molar ratio among the embodiment one, change 1.0: 0.8 into by former 1: 1, other processes are constant, and ideal product productive rate is 10.5%.
Embodiment five
Change embodiment one, sulfonic acid potassio phthalonitrile and phthalimidomethyl phthalonitrile molar ratio are 0.8: 1.0 in process (1) and the process (2), and other processes are constant, and ideal product productive rate is 11.0%.
Embodiment six
Synthetic method in process (4), replaces zinc acetate with the 6.8g ferrous chloride with embodiment one, and other processes and condition are constant, obtain two (sulfonic acid potassio) two (phthalimidomethyl) FePCs, productive rate 15%.
Embodiment seven
Synthetic method in process (4), replaces zinc acetate with the 7.0g cobaltous chloride with embodiment one, and other processes and condition are constant, obtain two (sulfonic acid potassio) two (phthalimidomethyl) phthalocyanine cobalts, productive rate 15%.
Embodiment eight
Synthetic method in process (4), replaces zinc acetate with the 7.0g Nickel dichloride. with embodiment one, and other processes and condition are constant, obtain two (sulfonic acid potassio) two (phthalimidomethyl) phthalocyanine nickel, productive rate 16%.
Embodiment nine
Synthetic method in process (4), replaces zinc acetate with the 7.0g copper chloride with embodiment one, and other processes are constant, obtain two (sulfonic acid potassio) two (phthalimidomethyl) CuPcs, productive rate 21%.
Embodiment ten
Synthetic method in process (4), replaces zinc acetate with aluminum chloride with embodiment one, and other processes are constant, obtains two (sulfonic acid potassio) two (phthalimidomethyl) aluminum phthalocyanine, productive rate 11%.
Reference material:
[1] gold mound, Chen Naisheng, Liu Ersheng etc., Chinese invention patent ZL96117137.5 State Intellectual Property Office of the People's Republic of China
[2]S.V?Kudrevich，H.Ali?and?J.E.Lier，J.Chem.Perkin.Trans.，1994，2767
[3]K.J.M.Nolan，M.Hu，C.C.Leznoff，Synlett，1997，393
[4]Takamitsu?Fukuda?and?Nagnoyashi，Chemistry?Letters，2002，866
Claims (7)
1, a kind of new preparation method of amphipathic phthalocyanine anticancer photosensitizer, it is characterized in that: with hydrophilic 4-sulfonic acid potassio phthalonitrile and lipophilic 4-phthalimidomethyl phthalonitrile is raw material, at first allow them in lithium alkoxide solution, react generation corresponding sulfonic acid potassio " half phthalocyanine " and phthalimidomethyl " half phthalocyanine " respectively as presoma, then, these two kinds of presomas are pressed corresponding mol ratio, in ethylene glycol, carry out ring-closure reaction, after reaction finishes, steam ethylene glycol, solid residue is dissolved in N, in the dinethylformamide (DMF), and adding corresponding metal salt, under 120-200 ℃ of temperature, react, making main component is the phthalocyanine metal complex of two (sulfonic acid potassio) two (phthalimidomethyls), by-product is to contain the phthalocyanine metal complex that sulfonic acid potassio and phthalimidomethyl number do not wait, by the column chromatography separation method, obtain target product at last---two (sulfonic acid potassio) two (phthalimidomethyl) phthalocyanine metal complexes.
2, the new preparation method of amphipathic phthalocyanine anticancer photosensitizer according to claim 1, it is characterized in that, be raw material with hydrophilic 4-sulfonic acid potassio phthalonitrile and lipophilic 4-phthalimidomethyl phthalonitrile respectively, the lithium metal that in methanol and ethylene glycol, adds 0.25-2 times of mole respectively, control reaction temperature is 50-100 ℃ of scope, response time 10-60 minute, generate hydrophilic and lipotropy half phthalocyanine respectively.
3, the new preparation method of amphipathic phthalocyanine anticancer photosensitizer according to claim 1 and 2, it is characterized in that: above-mentioned two kinds of hydrophilic and lipophilic half phthalocyanine, in mol ratio is 1: be solvent with the ethylene glycol during 0.8-1.2, reaction is 1-4 hour under reflux temperature, generates the amphipathic phthalocyanine lithium-complex.
4, the new preparation method of amphipathic phthalocyanine anticancer photosensitizer according to claim 1, it is characterized in that: in the DMF solvent, add zinc salt, iron salt, mantoquita, cobalt salt, nickel salt, aluminum salt respectively, in reaction temperature is 80-120 ℃, response time 1-6 hour, can generate the respective metal coordination compound of amphipathic phthalocyanine respectively.
5, the new preparation method of amphipathic phthalocyanine anticancer photosensitizer according to claim 3, it is characterized in that: in the DMF solvent, add zinc salt, iron salt, mantoquita, cobalt salt, nickel salt, aluminum salt respectively, in reaction temperature is 80-120 ℃, response time 1-6 hour, can generate the respective metal coordination compound of amphipathic phthalocyanine respectively.
6, a kind of application of amphipathic phthalocyanine anticancer photosensitizer is characterized in that: the amphipathic phthalocyanine metal complex can be used as the crude drug of the photosensitizer of optical dynamic therapy behind column chromatography separation, purification, be used for the optical dynamic therapy cancer.
7, a kind of application of amphipathic phthalocyanine anticancer photosensitizer, it is characterized in that: the above-mentioned amphipathic phthalocyanine metal complex in purified back is dissolved in by CREMOPHORE EL, 1,2-propylene glycol and normal saline are pressed in the mixed liquor of corresponding proportion composition, the injection of making can be used as the photosensitizer of optical dynamic therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410013492 CN1256946C (en) | 2004-07-15 | 2004-07-15 | Novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410013492 CN1256946C (en) | 2004-07-15 | 2004-07-15 | Novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1593424A true CN1593424A (en) | 2005-03-16 |
| CN1256946C CN1256946C (en) | 2006-05-24 |
Family
ID=34663020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410013492 Expired - Fee Related CN1256946C (en) | 2004-07-15 | 2004-07-15 | Novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1256946C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100441610C (en) * | 2006-11-11 | 2008-12-10 | 西北师范大学 | Polymer xifualkali phthalocyanin bimetal compound, its preparation method and application |
| CN102058603A (en) * | 2010-07-12 | 2011-05-18 | 福州大学 | Disubstituted zinc phthalocyanine composite, and preparation method and application thereof |
| CN108498855A (en) * | 2018-05-09 | 2018-09-07 | 福州大学 | A kind of antibacterial anti hemorrhagic colloidal sol and preparation method thereof |
-
2004
- 2004-07-15 CN CN 200410013492 patent/CN1256946C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100441610C (en) * | 2006-11-11 | 2008-12-10 | 西北师范大学 | Polymer xifualkali phthalocyanin bimetal compound, its preparation method and application |
| CN102058603A (en) * | 2010-07-12 | 2011-05-18 | 福州大学 | Disubstituted zinc phthalocyanine composite, and preparation method and application thereof |
| CN102058603B (en) * | 2010-07-12 | 2012-07-25 | 福州大学 | Disubstituted zinc phthalocyanine composite, and preparation method and application thereof |
| CN108498855A (en) * | 2018-05-09 | 2018-09-07 | 福州大学 | A kind of antibacterial anti hemorrhagic colloidal sol and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1256946C (en) | 2006-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101541791B (en) | Process for preparing nebivolol | |
| Stang et al. | Directed self‐assembly of chiral, optically active macrocyclic tetranuclear molecular squares | |
| WO2010027334A1 (en) | Novel tricyclic chiral compounds and their use in asymmetric catalysis | |
| CN111116677A (en) | Preparation method and application of metal-organic framework structure compound with chiral pore structure | |
| CN114591277B (en) | 5/6/7/6 tetracyclic compound fused with benzene ring and synthetic method thereof | |
| CN102174125B (en) | Preparation and application of novel CH2-N=C-Ar group-modified cyclodextrin derivatives | |
| CN1256946C (en) | Novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application | |
| Kumadaki et al. | Synthesis of fluorinated analogs of natural porphyrins potentially useful for the diagnosis and therapy of cancer | |
| CN111662567A (en) | Heptamethine carboxyl indole cyanine dye and preparation method and application thereof | |
| CN101735228A (en) | 5-(4-phenoxyacetic acid)-10,15,20-triphenyl zinc porphyrin and preparation method thereof | |
| CN101260110A (en) | Alpha-(8-quinolineoxy)mono-substituted zinc phthalocyanine and preparation method thereof | |
| Faux et al. | Preparation of enantiopure 1, 4-amino alcohols derived from [3] ferrocenophanes: use in the asymmetric addition of diethylzinc to benzaldehyde | |
| CN109912608A (en) | Hydroxyl replaces click to cough up complex and preparation method thereof | |
| CN111662568A (en) | Preparation method of heptamethine indole cyanine dye and application of dye | |
| CN112920095B (en) | Novel aggregation-induced emission endoplasmic reticulum fluorescent probe and preparation method and application thereof | |
| WO2007000918A1 (en) | Benzylamine derivatives, method for optical resolution of benzylamine derivatives, process for production of benzylamine derivatives, process for production of optically active benzylamine derivatives, and process for production of (1r, 2s)-2-amino-1-(4-hydroxyphenyl)propan-1-ol | |
| JPH1095759A (en) | Dendritic nitrogen-containing organic compound bearing planar chiral or axial chiral terminal group, its preparation and use | |
| CN108997406B (en) | Triphenylamine fluoro aryl benzyl ether branch ligand substituted silicon phthalocyanine and preparation method and application thereof | |
| CN108689957B (en) | Preparation method and application of 2R/2S-trifluoromethyl morpholine and hydrochloride thereof | |
| CN112574248A (en) | Preparation method of di- ((3-chlorobenzothiophene-2-ester group) hexafluorophenoxy) axial substituted silicon phthalocyanine | |
| CN111592484A (en) | Preparation method of 5-aminolevulinic acid hydrochloride intermediate | |
| CN111662565A (en) | Heptamethine nitroindole cyanine dye and preparation method and application thereof | |
| CN111662566A (en) | Heptamethine hydroxyindole cyanine dye, and synthesis method and application thereof | |
| US11731951B1 (en) | Water reactivity with natural products | |
| CN111320646B (en) | 1, 4-eneyne compound and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Changzhou Jiaerke Pharmaceutical Group Co., Ltd. Assignor: Fuzhou University Contract fulfillment period: 2007.6.15 to 2012.6.14 contract change Contract record no.: 2008320001030 Denomination of invention: Novel method for preparing anticancer photosensitizer of amphiphilic phthalocyanine and its application Granted publication date: 20060524 License type: Exclusive license Record date: 20081022 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2007.6.15 TO 2012.6.14; CHANGE OF CONTRACT Name of requester: CHANGZHOU JIAERKE PHARMACY GROUP CO.,LTD. Effective date: 20081022 |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060524 Termination date: 20120715 |